Erez Kalir - 06 Jan 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Director
Signature
/s/ Erez Kalir
Issuer symbol
VOR
Transactions as of
06 Jan 2025
Net transactions value
$0
Form type
4
Filing time
08 Jan 2025, 18:41:04 UTC
Next filing
23 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 06 Jan 2025 Common Stock 60,000 $1.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth of the shares subject to the option shall vest and become exercisable on February 6, 2025 and each month thereafter, subject to the Reporting Person's continued service through each such vesting date.

Remarks:

Mr. Kalir was elected to the board of directors of the Issuer as a designee of Reprogrammed Interchange LLC.